LUNGHI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4.788
EU - Europa 4.194
AS - Asia 2.874
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 4
SA - Sud America 4
Totale 11.930
Nazione #
US - Stati Uniti d'America 4.676
CN - Cina 1.716
IE - Irlanda 889
FI - Finlandia 792
SG - Singapore 732
SE - Svezia 694
IT - Italia 616
DE - Germania 528
UA - Ucraina 460
TR - Turchia 305
CA - Canada 109
GB - Regno Unito 76
IN - India 60
CI - Costa d'Avorio 45
FR - Francia 38
BE - Belgio 21
JP - Giappone 18
RO - Romania 18
AT - Austria 16
EU - Europa 16
IR - Iran 15
NL - Olanda 12
CZ - Repubblica Ceca 10
VN - Vietnam 10
DZ - Algeria 5
HK - Hong Kong 5
LT - Lituania 5
PK - Pakistan 5
CH - Svizzera 4
KR - Corea 4
ES - Italia 3
MX - Messico 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
LU - Lussemburgo 2
MD - Moldavia 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
CO - Colombia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
PL - Polonia 1
Totale 11.930
Città #
Dublin 889
Jacksonville 721
Chandler 674
Singapore 573
Beijing 408
Dearborn 394
Nanjing 276
Izmir 275
Boardman 273
Ashburn 250
San Mateo 236
Ann Arbor 217
Princeton 203
Wilmington 149
Parma 129
Shenyang 110
Toronto 95
Kunming 84
Jinan 83
Nanchang 82
Helsinki 79
Shanghai 79
Hebei 74
Hefei 59
Changsha 50
Jiaxing 50
Düsseldorf 49
Grafing 46
Abidjan 45
Woodbridge 45
Tianjin 44
Seattle 39
Santa Clara 36
New York 32
Guangzhou 31
Des Moines 30
Kocaeli 29
Norwalk 28
Pune 28
Zhengzhou 28
Los Angeles 26
Milan 25
Hangzhou 24
Brussels 21
Fremont 21
Leawood 21
Bremen 20
Houston 20
Bologna 18
Ningbo 18
Taizhou 18
Tokyo 18
Lanzhou 17
Rome 17
Augusta 16
Falls Church 16
Haikou 16
Fuzhou 14
Dallas 13
Vienna 13
Redmond 11
Borås 10
Dong Ket 10
Marseille 10
Munich 10
Trezzano Sul Naviglio 10
Auburn Hills 9
Modena 9
Monmouth Junction 9
Novara 9
Timisoara 9
Wuhan 9
Piacenza 8
Reggio Emilia 8
Rockville 8
Angri 7
Focsani 7
Mumbai 7
Redwood City 7
Reggio Nell'emilia 7
Torino 7
Verona 7
Ardabil 6
Arzano 6
Brno 6
Cambridge 6
Mountain View 6
New Delhi 6
Shaoxing 6
Zanjan 6
Chengdu 5
Chongqing 5
London 5
Mestre 5
Quzhou 5
Islamabad 4
Langhirano 4
Montréal 4
Padova 4
Pievepelago 4
Totale 7.675
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 203
Attività biologica del tiosemicarbazone del piridossale e dei suoi complessi di rame 139
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 129
The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways 127
L'attività della wortmannin inibitore della fosfatidilinositolo-3 chinasi su cellule di leucemia mieloide cronica in fase cronica 121
Endocanalicular transendothelial crossing (ETC): A novel intravasation mode used by HEK-EBNA293-VEGF-D cells during the metastatic process in a xenograft model 113
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 111
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 97
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 96
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 95
Alpha and Gamma interferons do not modulate the levels of JNK/SAPK activation in Ph+ leukemic cell lines 95
Air purification and indoor biologic pollutants 92
L'inibizione della proliferazione indotta dal tiosemicarbazone della 2-piridina carbossialdeide e dai relativi complessi di stagno in linee cellulari umane e in cellule derivate da pazienti leucemici è associata ad apotosi 91
Fosforilazione in tirosina delle proteine adattatrici SHC ed attivazione di ERK-JNK/SAPK kinasi in leucemia acuta mieloblastica 90
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 87
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 84
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 84
Transition-Metal Complexes of Isatin-beta-Thiosemicarbazone. X-Ray Crystal Structure of Two Nickel Complexes 84
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 83
2,6-Diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activity 82
Analisi dei meccanismi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 81
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 80
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 79
Acenaphthenequinone Thiosemicarbazone and Its Transition Metal Complexes: Synthesis, Structure, and Biological Activity 78
The ontogenesis of BCL2 oncogen protein in human hemopoietic development 77
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 76
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 74
An abatement of the concentration of mycophytes, dust mites and pollen grains in the indoor environment using an air purifier 73
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 72
Tyrosine-phosphorylation of SHC adaptor proteins and activation of ERK-JNK/SAPK MAP kinases in acute myelogenous leukemia 72
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 72
An abatement of the concentration of mycophytes, dust mites and pollens grains in the indoor environment using an air purifier 70
Attività biologica dei tiosemicarbazoni dell'acido alfa-chetoglutarico e della 2,6 diacetilpiridina 70
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 70
High levels of ERK constitutive activity in acute myelogenous leukemia 70
Analisi della chinasi ERK in leucemia acuta mieloblastica e malattie linfoproliferative croniche 69
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 69
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 69
Tyrosine phosphorylation of SHC adaptor proteins in chronic myelogenous leukemia 68
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 68
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 67
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 67
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 67
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 66
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 66
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 66
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 66
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 66
: Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 65
Selective inhibition of MEK1 kinase downmodulates ERK activity and proliferation of acute myeloid leukemia blasts 65
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 64
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 64
Acenapthenequinone thiosemicarbazone and its transition metal complexes. Synthesis, structure and biological activity 64
Le IgG normali e quelle di soggetti con lupus eritematoso sistemico esercitano un effetto pro-infiammatorio precoce su cellule tubulari umane 63
Riduzione di allergeni indoor con purificatore d’aria 63
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 63
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 63
Riduzione della concentrazione di micofiti, pollini e allergeni della polvere in ambienti confinati 63
p73 and p53 pathway in human breast cancers. 63
Attività della proteina del segnale ERK nell'auto-mantenimento, proliferazione e differenziazione delle cellule staminali ematopoietiche umane pluripotenti 63
Monitoring of emerging pollen grains in the Parma’s area (Northern Italy) 62
Attivazione costitutiva di ERK in leucemia acuta mieloblastica 62
High levels of P52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 62
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 62
Emerging MEK inhibitors 62
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 62
Chimica, struttura ed attività biologica di sistemi metallo-legante solforato 62
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure and biological activity 62
High levels of p52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 61
Selective inhibition of MEK1 kinase down-modulates ERK activity and proliferation of acute myeloid leukemia blasts 61
Phosphorylation of the SHC proteins in human leukemia 61
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 61
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 61
The reduction of the concentration of dust mites, mycophytes, and pollens grains in the indoor environment by means of an air purifier 61
Espressione dell'oncogene BCL2 in cellule emopoietiche fetali umane 61
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 60
Betulaceae, Corylaceae, Cupressaceae, Fagaceae and Salicaceae around Parma (Northern Italy): pollen calendars from 1995 to 1997, 60
The reduction of the concentration of dust mites, mycophites and pollen grains in the indoor environment by means of an air purifier 60
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 60
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 60
Synthesis, characterization, X-ray strucrure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 60
Blockade of Aurora kinases activity enhances APO2L/TRAIL sensitivity in multiple myeloma 59
Infezione HCV, crioglobulinemia mista e linfoma linfoplasmocitoide: una eziopatogenesi comune? 59
Analisi dei meccansimi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 59
Massive expansion and proliferation of human hematopoietic progenitors are uncoupled with sustained ERK activity 58
Emerging Raf inhibitors 58
Ontogenesi dell'oncogene BCL2 in tessuti emopoietici fetali 58
Riduzione della carica batterica aerodispersa mediante utilizzo di un purificatore d'aria in ambienti indoor 58
High levels of ERK constitutive activity in acute myelogenous leukemia 57
Betulaceae, Corylaceae, Cupressaceae, Fagaceae and Salicaceae around Parma (Northern Italy): pollen calendars from 1995 to 1997 57
An abatment of the concentration of mycophytes and pollen grains in the indoor environment using an air purifier 57
Constitutive expression and tyrosine phosphorylation of SHC proteins in chronic myelogenous leukemia 57
Selective inhibition of MEK! Kinase downmodulates ERK activity and prolifaretion of acute myeloid leukemia blasts 57
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 57
Down.modulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells 56
High self-renewal of human primitive hematopoietic stem cells taken from cord blood is uncoupled from sustained ERK activity 56
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 56
L'inibizione selettiva della chinasi ERK controlla la proliferazione dei blasti di leucemia mieloide acuta 56
SHC proteins phosphorylation in chronic myelogenous leukemia 56
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 55
Totale 7.223
Categoria #
all - tutte 45.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.703 0 0 0 0 214 272 355 64 199 314 89 196
2020/20211.289 9 112 119 6 218 35 105 14 333 53 253 32
2021/2022976 18 13 8 26 22 54 109 170 52 121 107 276
2022/20232.980 398 260 181 182 249 310 17 187 1.095 12 78 11
2023/20241.069 76 94 32 31 108 222 85 50 26 72 114 159
2024/20251.042 97 248 256 204 237 0 0 0 0 0 0 0
Totale 12.005